BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2527721)

  • 1. Delayed-type hypersensitivity reaction to heparin.
    Korstanje MJ; Bessems PJ; Hardy E; van de Staak WJ
    Contact Dermatitis; 1989 May; 20(5):383-4. PubMed ID: 2527721
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin.
    Koch P; Hindi S; Landwehr D
    Contact Dermatitis; 1996 Feb; 34(2):156-8. PubMed ID: 8681559
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eczematous infiltrated plaques to subcutaneous heparin: a type IV allergic reaction.
    Bircher AJ; Flückiger R; Buchner SA
    Br J Dermatol; 1990 Oct; 123(4):507-14. PubMed ID: 2151304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hypersensitivity reaction to heparin in a pregnant woman.
    Sanders MN; Bernhisel-Broadbent J; Staker LV
    Int J Dermatol; 1995 Jun; 34(6):443-4. PubMed ID: 7657449
    [No Abstract]   [Full Text] [Related]  

  • 7. Positivity of patch tests in cutaneous reaction to diclofenac. Two case reports.
    Romano A; Pietrantonio F; Di Fonso M; Garcovich A; Chiarelli C; Venuti A; Barone C
    Allergy; 1994 Jan; 49(1):57-9. PubMed ID: 8198241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous reactions to heparin: immunological and clinical aspects].
    Mathelier-Fusade P; Deschamps A; Abuaf N; Leynadier F
    Presse Med; 1995 Feb; 24(6):323-5. PubMed ID: 7899395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous adverse events associated with heparin.
    Maldonado Cid P; Alonso de Celada RM; Noguera Morel L; Feito-Rodríguez M; Gómez-Fernández C; Herranz Pinto P
    Clin Exp Dermatol; 2012 Oct; 37(7):707-11. PubMed ID: 22998541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed hypersensitivity reaction to heparin.
    O'Donnell BF; Tan CY
    Br J Dermatol; 1993 Nov; 129(5):634-6. PubMed ID: 8251369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evidence of delayed-type hypersensitivity to hydrocortisone.
    Wilkinson SM; English JS; Mattey DL
    Contact Dermatitis; 1993 Nov; 29(5):241-5. PubMed ID: 8112062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed systemic reactions with flare-ups of previously negative intradermal skin tests to heparin.
    García Robaina JC; Sánchez Machín I; Fernández-Caldas E; de la Torre Morín F
    Allergy; 2003 Jul; 58(7):685-6. PubMed ID: 12823138
    [No Abstract]   [Full Text] [Related]  

  • 13. Bullous Fixed Drug Eruption Caused by Etoricoxib Confirmed by Patch Testing.
    Carneiro-Leão L; Rodrigues Cernadas J
    J Allergy Clin Immunol Pract; 2019; 7(5):1629-1630. PubMed ID: 30777670
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy.
    Kim J; Smith KJ; Toner C; Skelton H
    Int J Dermatol; 2004 Apr; 43(4):252-60. PubMed ID: 15090006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable cutaneous allergic response to subcutaneous heparin--a case report.
    Gupta S; Mishra P; Palaian S; Prabhu S; Bista D; Prabhu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Jun; 15(2):98-101. PubMed ID: 16998611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous delayed hypersensitivity reactions to heparins and heparinoids].
    Figarella I; Barbaud A; Lecompte T; De Maistre E; Reichert-Penetrat S; Schmutz JL
    Ann Dermatol Venereol; 2001 Jan; 128(1):25-30. PubMed ID: 11226896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed-type hypersensitivity to oral and parenteral drugs.
    Brandt O; Bircher AJ
    J Dtsch Dermatol Ges; 2017 Nov; 15(11):1111-1132. PubMed ID: 29106000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases.
    Borgemeester RWK; van Laar T; Schuttelaar MLA
    Contact Dermatitis; 2018 Nov; 79(5):316-318. PubMed ID: 30123968
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous challenge with heparins in patients with delayed-type skin reactions after subcutaneous administration of the drug.
    Trautmann A; Bröcker EB; Klein CE
    Contact Dermatitis; 1998 Jul; 39(1):43-4. PubMed ID: 9686990
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity to enoxaparin.
    Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
    J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.